GSK has secured approval in Japan for Exdensur (depemokimab), the country’s first ultra-long-acting biologic for severe asthma and chronic rhinosinusitis with nasal polyps. Approved by Japan’s ...
Together, ZF and Qualcomm Technologies aim to deliver a future-proof ADAS compute platform that supports the rapid advancement of automated driving, enhances vehicle safety, and aligns with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback